Author:
Lopez-Gutierrez Javier,Cervantes B. Mario
Abstract
AbstractAchalasia is the result of a progressive degeneration process of the ganglion cells of the myenteric plexus, located in the esophageal wall. The disorder motility that characterizes achalasia appears to result primarily from the loss of inhibitory neurons within the wall of the esophagus itself. This loss of the inhibitory innervation in the LOS causes the basal sphincter pressure to rise and renders the sphincter muscle incapable of normal relaxation. The loss of inhibitory neurons from the smooth muscle portion of the esophageal body results in aperistalais [1]. The manifestations of the disease depend on the degree and location of ganglion cell loss [2]. Loss of peristalsis in the distal esophagus and LOS failure to relax with swallowing, both impair esophageal emptying. Most of the signs and symptoms of achalasia are due to the defect in LES relaxation. Esophagogastric junction (OGJ) outflow obstruction. The risk of developing esophageal cancer increases up to 3.3% after a mean symptom duration of 13 years [3].
Publisher
Springer Nature Singapore
Reference21 articles.
1. Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22:e256.
2. de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroentetol. 1995;90:1119.
3. Costigan DJ, Clouse RE. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci. 1983;28:763.
4. Dufrense CR, Jeyasingham K, Baker RR. Achalasia of the cardia associated with pulmonary sarcoidosis. Surgery. 1983;94:32.
5. Foster PN, Stewart M, Lowe JS, Atkinson M. Achalasia like disorders of the oesophagus in Von Recklinghausen’s neurofibromatosis. Gut. 1987;28:1522.